GE HealthCare (GEHC) PT Raised to $110 at Argus

Argus analyst David Toung raised the price target on GE HealthCare (NASDAQ: GEHC) to $110.00 (from $80.00) while maintaining a Buy rating.

The analyst comments "We are reaffirming our BUY rating on GE HealthCare Technologies Inc. (NGS: GEHC). The company provides advanced medical devices and related products that help in the screening, diagnosis, treatment, and monitoring of patients. It also focuses on precision care by utilizing new imaging and ultrasound technologies to bring diagnosis and treatments to individuals.
GE HealthCare was spun out of GE and began trading as an independent company in December 2022. The company has an experienced management team and leading positions in its target industries."

You May Also Be Interested In

• Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
• BWS Financial Downgrades Inter Parfums (IPAR) to Sell
• Deutsche Bank Downgrades Netskope (NTSK) to Hold on Valuation